Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpramipexole in ALS
NCT00647296Phase 2Completed
- Sponsor
- Knopp Biosciences
- Start
- Apr 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexpramipexole in amyotrophic lateral sclerosis (ALS), sponsored by Knopp Biosciences. Started Apr 2008; status: completed.
02
Drugs
dexpramipexole
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00647296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647296.